Advocacy News

SITC Hosts "Non-invasive Biomarkers for irAEs: Computational Science in Immuno-oncology" Webinar

By SITC Advocacy posted 12 days ago
On June 18, 2025, the Society for Immunotherapy of Cancer (SITC) in partnership with the National Cancer ...
0 comments

SITC Hosts "Lessons from the CIMAC-CIDC Network: Computational Science in Immuno-oncology" Webinar

By SITC Advocacy posted 06-04-2025
The focus of this webinar on May 29th, 2025 was exploring how machine learning-driven modeling of multimodal ...
0 comments

SITC Hosts "Guidelines and Best Practices on Designing Clinical Trials with Exploratory Surrogate Endpoints and CDX: Computational Science in Immuno-oncology" Webinar

By SITC Advocacy posted 05-15-2025
This webinar on May 8th discussed how exploratory surrogate endpoints and companion diagnostics (CDX) ...
0 comments

SITC Thanks Members for Participating in Their 2025 Capitol Hill Visits!

By SITC Advocacy posted 05-01-2025
SITC’s 2025 Capitol Hill Visits have officially concluded after engaging with over 25 congressional offices! ...
0 comments

SITC Statement on Major Staff Reductions at the Department of Health and Human Services

By SITC Advocacy posted 04-30-2025
Dear SITC Members, The Society for Immunotherapy of Cancer (SITC) strongly opposes the recent actions ...
0 comments

SITC’s 2025 Capitol Hill Visits!

By SITC Advocacy posted 04-29-2025
SITC is pleased to announce the kickoff of SITC’s 2025 in person Capitol Hill Visits! Over the last few ...
0 comments

SITC Hosts Advanced Biomarker Development and Clinical Translation: Computational Science in Immuno-oncology Webinar

By SITC Advocacy posted 04-09-2025
This webinar on April 2 explored what b iomarker discovery for cancer immunotherapy entails using ...
0 comments

Announcing the publication of “Society for Immunotherapy of Cancer (SITC) consensus statement on essential biomarkers for immunotherapy clinical protocols”

By SITC Advocacy posted 03-26-2025
The Society for Immunotherapy of Cancer (SITC) is pleased to announce the publication of a comprehensive ...
0 comments

Kick-off of SITC’s 2025 Capitol Hill Visits!

By SITC Advocacy posted 03-03-2025
SITC is pleased to announce the kickoff of SITC’s 2025 Capitol Hill Visits! SITC members are meeting ...
0 comments

SITC Statement on NIH to Indirect Costs

By SITC Advocacy posted 02-19-2025
SITC released a statement addressing their concerns for the recent announcement from the National Institutes ...
0 comments

SITC Participates in Sign on Letter to Support the AKACA

By SITC Advocacy posted 12-11-2024
SITC has recently signed on to a letter from the Leukemia Lymphoma Society advocating congress to pass ...
0 comments

SITC Hosts Tumor Biomarkers and Assessing PD-1: Increasing Access to IO Webinar

By SITC Advocacy posted 12-04-2024
This webinar on November 21st examined how biomarkers are used to define “PD-L1” positive patients around ...
0 comments

Annual Meeting Session Highlight: Cellular Therapies/Regulatory/Manufacturing

By SITC Advocacy posted 11-06-2024
Cellular therapies offer great promise as a cancer therapy. They are living biological drugs, and often ...
0 comments

Tumor Infiltrating Lymphocytes (TIL) Symposium

By SITC Advocacy posted 11-04-2024
As part of the 39th Annual Meeting & Pre-Conference Programs (SITC 2024), the SITC Tumor Infiltrating ...
0 comments

SITC Hosts Monitoring Response to Cancer Immunotherapy: Increasing Access to IO Webinar

By SITC Advocacy posted 10-30-2024
This webinar on October 16th examined the importance of monitoring response to cancer immunotherapy, ...
0 comments

SITC Hosts Rationalized Patient Match and Clinical Trial Design with Large/Moderate Language Models on EHR Data: AI in Immuno-Oncology Webinar

By SITC Advocacy posted 10-23-2024
Thousands of IO clinical trials are currently available to cancer patients, all of which are aiming to ...
0 comments

SITC Hosts Rare and Challenging Cases: Increasing Access to IO Webinar

By SITC Advocacy posted 10-09-2024
This webinar on September 26th examined how rare and challenging cases, such as extremes of age, immunocompromised, ...
0 comments

SITC Hosts Predicting Drug Resistance and Drug Repurposing with Imaging-Based AI: AI in Immuno-oncology Webinar

By SITC Advocacy posted 10-02-2024
Increased understanding of immunotherapy mechanisms of action may enhance researchers’ ability to circumvent ...
0 comments

SITC Comments on FDA Guidance

By SITC Advocacy posted 09-26-2024
SITC has provided comment on the recently posted "Diversity Action Plans to Improve Enrollment of Participants ...
0 comments

SITC Hosts Predicting Early Diagnosis and Response with Multimodal AI: AI in Immuno-Oncology Webinar

By SITC Advocacy posted 09-16-2024
Earlier cancer diagnosis, as well as rapid determination of tumor response after treatment, could lead ...
0 comments